|
WDC
|
Technology |
Melius |
Initiates
|
Buy
|
$1050
|
$223.3B
|
$586.45
|
+2.4%
|
+11.2%
|
-2.0%
|
-6.3%
|
-9.9%
|
+7.1%
|
|
STX
|
Technology |
Melius |
Initiates
|
Buy
|
$1600
|
$219.1B
|
$899.90
|
+1.8%
|
+7.6%
|
-0.4%
|
-5.2%
|
-10.4%
|
+5.9%
|
|
MCD
|
Consumer Cyclical |
KeyBanc Capital Markets |
Reiterates
|
Overweight
|
$315
|
$191.7B
|
$269.76
|
+0.2%
|
-1.0%
|
+1.2%
|
-0.3%
|
+4.2%
|
-0.4%
|
|
CRWD
|
Technology |
Arete |
Downgrade
|
Buy
→
Neutral
|
$730
|
$178.5B
|
$175.27
|
+1.2%
|
+6.0%
|
+2.7%
|
+1.3%
|
+0.4%
|
+2.8%
|
|
APP
|
Technology |
Raymond James |
Initiates
|
Strong Buy
|
$640
|
$160.3B
|
$477.08
|
+2.8%
|
+4.5%
|
+3.3%
|
+9.6%
|
-6.7%
|
+3.2%
|
|
PGR
|
Financial Services |
Wells Fargo |
Downgrade
|
Equal Weight
→
Underweight
|
$205
|
$131.1B
|
$224.34
|
-1.4%
|
-2.0%
|
-0.6%
|
+3.1%
|
+3.1%
|
-0.2%
|
|
URI
|
Industrials |
BNP Paribas Exane |
Upgrade
|
Neutral
→
Outperform
|
$1320
|
$70.3B
|
$1121.66
|
-0.0%
|
+0.1%
|
+0.9%
|
-1.9%
|
-1.2%
|
+0.1%
|
|
WBD
|
Communication Services |
Seaport Research Partners |
Upgrade
|
Neutral
→
Buy
|
$31
|
$67.0B
|
$26.74
|
+0.4%
|
+1.5%
|
-1.7%
|
+0.6%
|
-1.2%
|
-1.4%
|
|
STM
|
Technology |
BarclaysB |
Upgrade
|
Underweight
→
Equal Weight
|
—
|
$63.5B
|
$71.42
|
+1.8%
|
+4.7%
|
+0.1%
|
-5.6%
|
-3.4%
|
+4.4%
|
|
RBLX
|
Technology |
Arete |
Upgrade
|
Neutral
→
Buy
|
$95
|
$34.0B
|
$47.56
|
+7.0%
|
+14.3%
|
+0.1%
|
+6.6%
|
-4.4%
|
+2.9%
|
|
CASY
|
Consumer Cyclical |
BMO Capital Markets |
Upgrade
|
Market Perform
→
Outperform
|
$950
|
$28.8B
|
$778.63
|
+1.8%
|
+0.2%
|
+1.9%
|
-1.3%
|
+1.7%
|
+1.2%
|
|
GNRC
|
Industrials |
Barclays |
Reiterates
|
Equal Weight
|
$285
|
$16.5B
|
$278.62
|
+0.1%
|
+1.9%
|
+3.2%
|
-7.7%
|
-6.5%
|
+2.0%
|
|
WULF
|
Financial Services |
Citigroup |
Initiates
|
Buy
|
$36
|
$12.6B
|
$25.83
|
+2.9%
|
-1.0%
|
-3.4%
|
-4.5%
|
-10.2%
|
+4.9%
|
|
U
|
Technology |
Raymond James |
Initiates
|
Mkt Perform
|
—
|
$12.4B
|
$28.23
|
+1.8%
|
+0.3%
|
+1.0%
|
+5.6%
|
-2.9%
|
+1.1%
|
|
VSAT
|
Technology |
Oppenheimer |
Initiates
|
Outperform
|
$140
|
$10.5B
|
$61.95
|
+8.8%
|
+23.8%
|
+17.1%
|
-7.6%
|
+0.0%
|
+0.9%
|
|
CYTK
|
Healthcare |
UBSB |
Upgrade
|
Neutral
→
Buy
|
$115
|
$10.2B
|
$82.19
|
+3.4%
|
+6.2%
|
-2.4%
|
+0.1%
|
+1.4%
|
-1.1%
|
|
ALKS
|
Healthcare |
BofA Securities |
Downgrade
|
Neutral
→
Underperform
|
$38
|
$9.2B
|
$55.08
|
-2.1%
|
-4.6%
|
-0.2%
|
-1.3%
|
+5.5%
|
+1.0%
|
|
YMM
|
Technology |
JP MorganA |
Upgrade
|
Neutral
→
Overweight
|
$10
|
$8.1B
|
$7.72
|
+3.9%
|
+4.7%
|
+0.5%
|
+4.2%
|
-0.4%
|
+2.8%
|
|
LQDA
|
Healthcare |
BofA Securities |
Downgrade
|
Buy
→
Neutral
|
$79
|
$7.0B
|
$78.17
|
-1.8%
|
-3.9%
|
+6.1%
|
-0.5%
|
-0.5%
|
+0.4%
|
|
SEZL
|
Financial Services |
Oppenheimer |
Downgrade
|
Outperform
→
Perform
|
—
|
$5.7B
|
$170.56
|
-1.1%
|
+0.1%
|
+0.5%
|
+2.1%
|
+4.6%
|
-2.3%
|